The latest data on holistic care and weight loss meds

I'm back from my holiday & from my inbox it's clear that weight loss medications are still attracting a lot of curiosity, & with good reason.

For decades, the management of overweight and obesity has centred around lifestyle intervention.

Increase physical activity. Reduce calorie intake. 

And whilst lifestyle change remains the cornerstone of weight management and continues to be the first-line approach within clinical practice, many people will recognise the challenge that has always existed. 

Making changes is one thing. Maintaining them is quite another. 

Long-term success has often been undermined by difficulties with adherence, uncertainty around what changes are actually required, and the all-too-common experience of weight regain. 

It is these challenges that have fuelled the development of alternative approaches and brought us to where we are today: the era of GLP-1 receptor agonists. 

Medications such as Mounjaro, Wegovy and Ozempic have transformed the landscape of obesity treatment and the results have been remarkable. 

By increasing satiety, reducing appetite, slowing gastric emptying and reducing overall calorie intake, these medications have demonstrated average weight reductions of around 15-25% over one to three years in clinical trials. In some cases, those outcomes approach those seen following certain forms of bariatric surgery. 

For many people, these medications have been life-changing. What is clear, however, is that they are not a complete solution in isolation. 

As with so many aspects of health, the most successful outcomes tend to come when medication is combined with broader lifestyle support. 

One reason for this is the side effect profile. 

The most commonly reported adverse effects are gastrointestinal, including nausea, vomiting, diarrhoea and constipation. 

For some individuals these symptoms are temporary or dose-dependent. For others, they can have a meaningful, ongoing impact on quality of life. 

Beyond those immediate effects, researchers are also paying close attention to longer-term considerations. 

Rapid and substantial weight loss, regardless of how it's achieved, raises important questions around muscle mass, bone health, frailty and healthy ageing. 

Many individuals living with overweight or obesity already have underlying micronutrient deficiencies. Not because they necessarily eat too much food, but because the foods they consume may be energy-dense but nutrient-poor. 

When appetite is subsequently suppressed by medication, existing deficiencies may be exacerbated. 

Nutrition support remains an important part of the conversation. 

Recent recommendations from nutrition and lifestyle medicine organisations are remarkably consistent in their messaging. 

The first principle is that treatment should be patient-centred. 

Whether we are discussing medication, lifestyle change or any other intervention, meaningful change is most likely to occur when it is driven by the individual themselves rather than external pressure. 

The second principle is careful assessment. 

What does somebody's current diet actually look like? 

What does their nutritional status look like at baseline? 

What do their blood markers tell us? 

What support might be required to optimise health throughout the process? 

Without understanding the starting point, it becomes much harder to identify what needs attention. 

The third consideration is the management of side effects. 

Food choices, hydration & meal timings all matter.  

High-fat diets appear to worsen gastrointestinal symptoms for many individuals taking GLP-1 meds. Low fibre intake and inadequate fluid consumption can contribute further to digestive difficulties. 

At a time when appetite is reduced, every mouthful becomes more important. 

The emphasis is on nutrient density more than ever. Protein, fibre & micronutrients are all priorities.  

The goal is not simply eating less. It is ensuring the body receives what it needs despite consuming fewer calories. 

Protein intake deserves particular attention. Alongside resistance exercise, adequate protein helps preserve lean muscle mass during weight loss. 

This matters because muscle supports metabolic health. It supports mobility & healthy ageing. Maintaining muscle becomes increasingly important as we move through midlife and beyond. 

The conversation also extends well beyond food. 

Current guidance encourages practitioners to look holistically at the individual. 

How active or sedentary are they? How well are they sleeping? How much stress are they under? 

What role do alcohol, smoking or other medications play? Do they feel socially connected and supported? 

These factors all influence long-term outcomes. 

My own professional body, the British Society of Lifestyle Medicine (BANt), recently issued a joint statement highlighting the importance of wraparound care for people using these medications. 

The recommendation is not simply to focus on what the scales say. Instead, the focus should be broader. 

What matters most to the individual? 

What health outcomes are they hoping to achieve? 

How can support be personalised to help them get there? That support may involve clinicians, pharmacists, nutrition professionals, health coaches, mental health practitioners and community resources working together. 

It may also include planning for what happens next. 

How will progress be monitored? 

How will medications be adjusted if necessary? 

How will blood sugar, blood pressure and other health markers be reviewed as weight loss occurs? 

Significant weight loss can affect the dosing requirements of several medications, including those used for blood pressure, diabetes and other chronic conditions so forward planning matters. 

Ultimately, effective use of GLP-1 medications is about much more than obtaining a prescription and administering a weekly injection. 

The strongest outcomes come when medication sits within a broader framework of support covering nutrition, movement, sleep, stress management, community & understanding the factors that contributed to weight gain in the first place. 

Weight loss may be the initial goal. Long-term health is the bigger prize. 

Before I finish, a quick reminder that our next Menopause Café will take place on 7th July at 6pm at Vibe Café. 

This is a slight change from the date originally discussed, as Vibe will be closed towards the end of June. 

If you would like a supportive, informal space to discuss symptoms, challenges and solutions with other women navigating midlife, I would love to see you there. You can find more info on the event here.

And finally, for anyone currently using Mounjaro, Wegovy, Ozempic or similar medications and looking for structured support alongside treatment, remember that I also offer a programme specifically designed to complement these therapies. 

The focus is not simply weight loss. 

It is helping you build the habits, knowledge and resilience needed to maximise results and maintain them for the long term. 

If you would like to know more about either the Menopause Café or ongoing support, simply drop me a message. 

I'd be delighted to hear from you.